JP5934196B2 - 直接クローニング - Google Patents

直接クローニング Download PDF

Info

Publication number
JP5934196B2
JP5934196B2 JP2013513806A JP2013513806A JP5934196B2 JP 5934196 B2 JP5934196 B2 JP 5934196B2 JP 2013513806 A JP2013513806 A JP 2013513806A JP 2013513806 A JP2013513806 A JP 2013513806A JP 5934196 B2 JP5934196 B2 JP 5934196B2
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
rece
linear
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013513806A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013530689A (ja
JP2013530689A5 (enExample
Inventor
ユーミン チャン
ユーミン チャン
ジュン フー
ジュン フー
フランシス スチュワート
フランシス スチュワート
Original Assignee
ジーン ブリッジス ゲゼルシャフト ミット ベシュレンクテル ハフツング
ジーン ブリッジス ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジーン ブリッジス ゲゼルシャフト ミット ベシュレンクテル ハフツング, ジーン ブリッジス ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ジーン ブリッジス ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2013530689A publication Critical patent/JP2013530689A/ja
Publication of JP2013530689A5 publication Critical patent/JP2013530689A5/ja
Application granted granted Critical
Publication of JP5934196B2 publication Critical patent/JP5934196B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/16—Exonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters (3.16)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2013513806A 2010-06-10 2011-06-10 直接クローニング Active JP5934196B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1009732.7A GB201009732D0 (en) 2010-06-10 2010-06-10 Direct cloning
GB1009732.7 2010-06-10
PCT/IB2011/052549 WO2011154927A2 (en) 2010-06-10 2011-06-10 Direct cloning

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016093169A Division JP2016135158A (ja) 2010-06-10 2016-05-06 直接クローニング

Publications (3)

Publication Number Publication Date
JP2013530689A JP2013530689A (ja) 2013-08-01
JP2013530689A5 JP2013530689A5 (enExample) 2014-07-10
JP5934196B2 true JP5934196B2 (ja) 2016-06-15

Family

ID=42471456

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013513806A Active JP5934196B2 (ja) 2010-06-10 2011-06-10 直接クローニング
JP2016093169A Pending JP2016135158A (ja) 2010-06-10 2016-05-06 直接クローニング

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016093169A Pending JP2016135158A (ja) 2010-06-10 2016-05-06 直接クローニング

Country Status (8)

Country Link
US (2) US10443051B2 (enExample)
EP (2) EP3138921A1 (enExample)
JP (2) JP5934196B2 (enExample)
CN (2) CN103068995B (enExample)
CA (1) CA2802167C (enExample)
GB (1) GB201009732D0 (enExample)
SG (1) SG186219A1 (enExample)
WO (1) WO2011154927A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201009732D0 (en) 2010-06-10 2010-07-21 Gene Bridges Gmbh Direct cloning
EP2612918A1 (en) * 2012-01-06 2013-07-10 BASF Plant Science Company GmbH In planta recombination
CN102558309B (zh) * 2012-02-10 2014-09-17 浙江大学 一对转录激活子样效应因子核酸酶及其编码基因与应用
CN102627691B (zh) * 2012-04-05 2014-09-17 浙江大学 一对转录激活子样效应因子核酸酶及其编码基因与应用
JP6275120B2 (ja) * 2012-04-25 2018-02-07 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 大きい標的化ベクターによるヌクレアーゼ媒介標的化
CN102702335B (zh) * 2012-05-23 2014-07-09 上海斯丹赛生物技术有限公司 重组转录激活子样效应因子、转录激活子样效应因子核酸酶及其编码基因及应用
US20150267210A1 (en) 2012-10-16 2015-09-24 Genebridges Gmbh Electrocompetent cells and preparation thereof
EP3456831B1 (en) 2013-04-16 2021-07-14 Regeneron Pharmaceuticals, Inc. Targeted modification of rat genome
MX388127B (es) 2013-12-11 2025-03-19 Regeneron Pharma Metodos y composiciones para la modificacion dirigida de un genoma.
AU2014368982B2 (en) * 2013-12-19 2021-03-25 Amyris, Inc. Methods for genomic integration
BR112016028564A2 (pt) 2014-06-06 2018-01-30 Regeneron Pharma método para modificar um locus-alvo em uma célula.
MX384887B (es) 2014-06-23 2025-03-14 Regeneron Pharma Ensamblaje de adn mediado por nucleasa.
SG10201911411YA (en) 2014-06-26 2020-02-27 Regeneron Pharma Methods and compositions for targeted genetic modifications and methods of use
CA3176380A1 (en) 2014-11-21 2016-05-26 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modification using paired guide rnas
CN105713885B (zh) * 2014-12-04 2019-06-11 清华大学 特异识别并修复β地中海贫血症beta-globin基因的嵌合核酸酶
BR112017013104A2 (pt) * 2014-12-19 2018-05-15 Regeneron Pharma métodos para modificar um locus genômico alvo em uma célula, para intensificar a recombinação homóloga em um locus genômico alvo em uma célula e para produzir uma geração f0 de um animal não humano.
CN105734061B (zh) * 2016-03-25 2019-07-23 中国农业科学院生物技术研究所 从毕赤酵母中分离的鼠李糖诱导型启动子及其应用
CN109715813A (zh) * 2016-04-06 2019-05-03 基因桥有限公司 腺病毒载体
CN106995813B (zh) * 2017-03-23 2020-06-16 山东大学 基因组大片段直接克隆和dna多分子组装新技术
CN109385417A (zh) * 2017-08-03 2019-02-26 华东理工大学 体内dna无缝组装方法
MX2021012158A (es) * 2019-04-05 2022-01-06 Danisco Us Inc Métodos para la integración de una secuencia de adn donante en el genoma de bacillus usando constructos de adn recombinante lineal y composiciones de los mismos.
CN110184287B (zh) * 2019-05-24 2024-01-30 华南农业大学 一种制备重组病毒的方法及其应用
CN114630910A (zh) 2019-06-25 2022-06-14 伊纳瑞农业技术有限公司 改善的同源依赖修复基因组编辑
CN115717152A (zh) * 2022-11-29 2023-02-28 江南大学 一种控制枯草芽孢杆菌基因组同源重组概率的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043272A (en) 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
US5776744A (en) * 1995-06-07 1998-07-07 Yale University Methods and compositions for effecting homologous recombination
ATE449844T1 (de) 1997-12-05 2009-12-15 Europ Lab Molekularbiolog Neue methode zur klonierung dns unter anwendung des e. coli rece/rect rekombinationssystems
AUPP684998A0 (en) * 1998-10-30 1998-11-26 Murdoch Institute for Research into Birth Defects Limited, The A method of recombination and agents useful for same
US6355412B1 (en) * 1999-07-09 2002-03-12 The European Molecular Biology Laboratory Methods and compositions for directed cloning and subcloning using homologous recombination
US6569681B1 (en) * 2000-03-14 2003-05-27 Transkaryotic Therapies, Inc. Methods of improving homologous recombination
EP1399546A2 (en) 2001-02-09 2004-03-24 Gene Bridges GmbH Recombination method
WO2003010322A1 (en) * 2001-07-20 2003-02-06 Youming Zhang Improved rect or recet cloning and subcloning method
EP1590468A2 (en) * 2003-01-28 2005-11-02 Cellectis Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
WO2007013979A2 (en) 2005-07-20 2007-02-01 Invitrogen Corporation Methods for increasing efficiency of homologous recombination
KR100681815B1 (ko) * 2005-12-02 2007-02-12 한국생명공학연구원 리컴비네이즈 매개 선택표지 유전자 발현유도에 의한 목표유전자 간편 클로닝 및 목표 단백질 신속 발현 방법.
EP2027313B1 (en) * 2006-03-27 2012-05-16 Children's Hospital & Regional Medical Center Compositions and methods comprising the use of cell surface displayed homing endonucleases
GB0803109D0 (en) * 2008-02-20 2008-03-26 Gene Bridges Gmbh Method of nucleic acid recombination
JP2011217736A (ja) * 2010-03-26 2011-11-04 Aichi Medical Univ 組換えクラミジア及びその製造方法
GB201009732D0 (en) * 2010-06-10 2010-07-21 Gene Bridges Gmbh Direct cloning

Also Published As

Publication number Publication date
US20130210681A1 (en) 2013-08-15
JP2013530689A (ja) 2013-08-01
WO2011154927A9 (en) 2013-01-24
US12195732B2 (en) 2025-01-14
CN103068995A (zh) 2013-04-24
WO2011154927A3 (en) 2012-02-16
SG186219A1 (en) 2013-01-30
CN109825486A (zh) 2019-05-31
JP2016135158A (ja) 2016-07-28
CA2802167C (en) 2023-03-07
US20200283759A1 (en) 2020-09-10
GB201009732D0 (en) 2010-07-21
WO2011154927A2 (en) 2011-12-15
EP3138921A1 (en) 2017-03-08
CN103068995B (zh) 2020-10-16
EP2580338B1 (en) 2016-10-05
CA2802167A1 (en) 2011-12-15
US10443051B2 (en) 2019-10-15
EP2580338A2 (en) 2013-04-17

Similar Documents

Publication Publication Date Title
JP5934196B2 (ja) 直接クローニング
Murphy λ recombination and recombineering
JP7223377B2 (ja) 熱安定性ｃａｓ９ヌクレアーゼ
ES2902210T3 (es) Nueva técnica para la clonación directa de fragmentos genómicos grandes y el ensamblaje multimolecular de ADN
JP2019526248A (ja) プログラム可能ｃａｓ９−リコンビナーゼ融合タンパク質およびその使用
JP7328695B2 (ja) 安定で副作用の少ないゲノム編集用複合体及びそれをコードする核酸
JP2007020583A (ja) 操作された組換え部位を使用する組換えクローニング
CN102027112B (zh) 核酸重组方法
US20230183678A1 (en) In-cell continuous target-gene evolution, screening and selection
CN115552002A (zh) 基因组改造方法及基因组改造试剂盒
JP2019500036A (ja) 原核生物におけるｄｎａ末端修復経路の再構築
US20250243514A1 (en) Compositions, methods, and systems for dna modification
WO2022095929A1 (en) Transferable type i-f crispr-cas genome editing system
Shukla et al. Fehér, T. inPOSE: A Flexible Toolbox for Chromosomal Cloning and Amplification of Bacterial Transgenes. Microorganisms 2022, 10, 236
Kaur Using retrons to reverse resistance to a “last resort” antibiotic
Petassi Dual Pathway Transposition with Tn7-Like Elements: Safe Sites, Mobile Plasmids, and CRISPR-Cas
Haydaychuk Characterizing SaCas9 and SaCas9 [D10E] tolerance to mismatches using Directed Evolution Using Fluorescence Activated Cell Sorting (DEUFACS)
EP4097224A1 (en) Tools and methods for mycoplasma engineering
DK2825654T3 (en) SYSTEMS, PROCEDURES, AND COMPOSITIONS WITH CRISPR-CAS COMPONENTS FOR SEQUENCE MANIPULATION.
Compton et al. T-Loops, T-Circles and Slippery Forks

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140522

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140522

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150629

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150924

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151225

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160404

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160506

R150 Certificate of patent or registration of utility model

Ref document number: 5934196

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250